Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,372,362
+$935,130 QoQ
Shares Held
64,920
+18.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#289
of 971 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Waverly Advisors, LLC holds $63,053,306 across 13 Medical Devices names. DXCM ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
43,388 | $13,660,277 | |
| 2 | ABT |
Abbott Laboratories
|
137,186 | $12,448,257 | |
| 3 | MDT |
Medtronic plc
|
116,780 | $9,135,699 | |
| 4 | BSX |
Boston Scientific Corp
|
164,689 | $7,028,926 | |
| 5 | STE |
STERIS plc
|
32,456 | $6,834,259 | |
| 6 | DXCM |
Dexcom Inc
This page
|
64,920 | $4,372,362 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
55,905 | $3,578,478 | |
| 8 | EW |
Edwards Lifesciences Corp
|
31,413 | $2,841,619 |
All Filings in DXCM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,372,362 | 64,920 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,437,232 | 54,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,830,683 | 27,583 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,219,019 | 47,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $266,147 | 3,049 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $210,538 | 3,083 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $258,196 | 3,320 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||